ALI in Cancer Patients

Launched by ASSIUT UNIVERSITY · Mar 12, 2025

Keywords

ClinConnect Summary

This clinical trial, titled "ALI in Cancer Patients," is focused on understanding how acute limb ischemia (ALI)—a condition where blood flow to the limbs is suddenly reduced—affects cancer patients. The researchers want to evaluate the outcomes of these patients who are treated for ALI at their medical center. Essentially, the goal is to learn more about how this serious condition impacts those already battling cancer, which can help improve care and treatment options in the future.

To be eligible for this trial, patients need to have an active cancer diagnosis and present with ALI at the Vascular and Endovascular Surgery department. However, patients who have benign tumors (non-cancerous) or those who experience limb ischemia due to certain cancer treatments will not be included. Since the trial is not yet recruiting participants, those interested will have the opportunity to learn more about what the study involves once it begins. Participants can expect to undergo assessments and treatments applicable to their condition, and their experiences will contribute valuable information to the medical community.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • All cancer patient presented to Vascular and Endovascular surgery departement with ALI.
• Exclusion Criteria:
• • Patients with benign tumors or without active malignancy.
• • Patients with iatrogenic limb ischemia related to a tumor chemoembolization procedure.